Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension

By sjmartinez • July 1, 2022

Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ. 2022 Jul 1;12(3):e12127. doi: 10.1002/pul2.12127. PMID: 36016668; PMCID: PMC9395696.

Tags: Epidemiology, interstitial lung disease, prognosis, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, symptom assessment and management

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes

Lee L, Cao S, Miles CB, Troy MP, Moriarty JM. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.[...]

Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy

Bondar G, Mahapatra AD, Silacheva I, Bao TM, Vu T, Su S, Hairapetian A, Katappagari A, Galan L, Chandran J, Adamov R, Yang A, Bukkapatnam[...]

Clinical association between current depressive symptoms and odds ratio product in US sleep centers

Defillo A, Grassi M, Daccò S, Martin JL, Guadagni V. Clinical association between current depressive symptoms and odds ratio product in US sleep centers. Front[...]